Clinical Study
Relationships of Adiponectin with Markers of Systemic Inflammation and Insulin Resistance in Infants Undergoing Open Cardiac Surgery
Table 1
Baseline characteristics and operative data of infants (
).
| Characteristics | Data |
| Male gender (%) | 36 (60%) | Age (year) | 1.5 ± 0.4 | Body weight (kg) | 5.9 ± 1.7 | Left ventricular ejection fraction (%) | 67.4 ± 8.6 | Cardiopulmonary bypass time (min) | 50.3 ± 7.9 | Cross-clamping time (min) | 35.4 ± 4.3 | Cardiopulmonary bypass flow (L/min/m2) | 2.8 ± 0.4 | Ultrafiltration (mL/kg) | 337 ± 32 | Insulin (μU/mL) | 7.8 ± 1.6 | Blood glucose level (mmol/L) | 4.6 ± 0.5 | Tumor necrosis factor-α (pg/mL) | 32.7 ± 10.4 | Interleukin-6 (pg/mL) | 19.9 ± 15.7 | Adiponectin (μg/mL) | 9.5 ± 1.2 |
|
|
Data are presented as the number (%) of patients or mean values ± SD.
|